A spectacle lens designed to slow the progression of myopia can, for the first time, be marketed as a myopia control device in the United States.
In a landmark decision, the U.S. Food and Drug Administration has cleared Essilor’s new Stellest eyeglass lenses for sale—the first FDA-cleared eyeglass lenses shown in clinical trials to slow the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results